Tianjin, China

Yi Liu

This inventor holds 2 USPTO granted patents and 2 published patent applications. Top assignees: Chinese Academy of Medical Sciences, Chinese Academy of Sciences. Active years: 2022-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yi Liu. Retrieved from https://idiyas.com/inventor/yi-liu-pul4zgks

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2022-2025

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Yi Liu: Innovator in Recombinant Yeast Technology

Introduction

Yi Liu is a prominent inventor based in Tianjin, China. He has made significant contributions to the field of biotechnology, particularly in the development of recombinant yeast. His innovative work has led to advancements that are beneficial for industrial applications.

Latest Patents

Yi Liu holds two notable patents related to recombinant yeast. His latest patents focus on a recombinant yeast that expresses germacrene A synthetase or a fusion protein thereof. This fusion protein combines germacrene A synthetase and farnesyl pyrophosphate synthase. The recombinant yeast developed by Liu improves the yield of germacrene A, making it suitable for the industrialized production of β-elemene and/or germacrene A.

Career Highlights

Throughout his career, Yi Liu has worked with esteemed institutions such as the Chinese Academy of Sciences and the Chinese Academy of Medical Sciences. His research has been pivotal in advancing the understanding and application of recombinant yeast technology.

Collaborations

Some of his notable coworkers include Xueli Zhang and Luqi Huang. Their collaborative efforts have contributed to the success of various projects in the field of biotechnology.

Conclusion

Yi Liu's innovative work in recombinant yeast technology showcases his dedication to advancing biotechnological applications. His patents and collaborations reflect his significant impact on the industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…